Literature DB >> 19798558

Altered mitochondria, energy metabolism, voltage-dependent anion channel, and lipid rafts converge to exhaust neurons in Alzheimer's disease.

Isidre Ferrer1.   

Abstract

Beta-amyloid (Abeta) deposition, in the form of plaques and amyloid angiopathy, and hyper-phosphorylated tau deposition forming neurofibrillary tangles, dystrophic neurites around beta-amyloid plaques and neuropil threads, are neuropathological hallmarks of Alzheimer's disease (AD) that accumulate in the brain with disease progression. These changes are accompanied by progressive loss of synapses and nerve cell death. Progressive cognitive impairment and dementia are the main neurological deficits. In addition, there is cumulative evidence demonstrating other metabolic disturbances that impair cell function and hamper neuron viability. The main components of the mitochondria are altered: complex IV of the respiratory chain is reduced; complex V which metabolizes ADP to form ATP is oxidatively damaged and functionally altered; and voltage-dependent anion channel VDAC, a major component of the outer mitochondrial membrane that regulates ion fluxes, is damaged as a result of oxidative stress. Mitochondria are a major source of reactive oxygen species that promote oxidative damage to DNA, RNA, proteins and lipids. Protein targets of oxidative damage are, among others, several enzymatic components of the glycolysis, lipid metabolism and cycle of the citric acid that fuel oxidative phosphorylation, mitochondrial respiration and energy production. The lipid composition of lipid rafts, key membrane specializations that facilitate the transfer of substrates, and protein-protein and lipid-protein interactions, is altered as a result of the abnormally low levels of n-3 long chain polyunsaturated fatty acids (mainly docosahexaenoic acid) that increase viscosity and augment energy consumption. Abnormal lipid raft composition may also modify the activity of key enzymes that modulate the cleavage of the amyloid precursor protein to form toxic Abeta. This is further complicated by the disruption of the complex VDAC with estrogen receptor alpha at the caveolae which participates, under physiological conditions, in the protection against beta-amyloid. Together, all these alterations converge in reduced energy production and increased energy demands in altered cells. Cell exhaustion is suggested as being a determining element to interpret impaired neuron function, reduced molecular turnover, and enhanced cell death.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798558     DOI: 10.1007/s10863-009-9243-5

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  75 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  The voltage-dependent anion channel (VDAC): function in intracellular signalling, cell life and cell death.

Authors:  V Shoshan-Barmatz; A Israelson; D Brdiczka; S S Sheu
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

Review 3.  Measurement of VDAC permeability in intact mitochondria and in reconstituted systems.

Authors:  Marco Colombini
Journal:  Methods Cell Biol       Date:  2007       Impact factor: 1.441

Review 4.  The caveolae membrane system.

Authors:  R G Anderson
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

5.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

6.  Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein.

Authors:  Joanna M Cordy; Ishrut Hussain; Colin Dingwall; Nigel M Hooper; Anthony J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-22       Impact factor: 11.205

7.  Dystrophic neurites of senile plaques in Alzheimer's disease are deficient in cytochrome c oxidase.

Authors:  Esther Pérez-Gracia; Benjamín Torrejón-Escribano; Isidre Ferrer
Journal:  Acta Neuropathol       Date:  2008-07-16       Impact factor: 17.088

8.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

9.  Redox proteomic identification of 4-hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease.

Authors:  Tanea Reed; Marzia Perluigi; Rukhsana Sultana; William M Pierce; Jon B Klein; Delano M Turner; Raffaella Coccia; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2008-01-05       Impact factor: 5.996

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  55 in total

1.  Maternal Hypermethioninemia Affects Neurons Number, Neurotrophins Levels, Energy Metabolism, and Na+,K+-ATPase Expression/Content in Brain of Rat Offspring.

Authors:  Bruna M Schweinberger; André F Rodrigues; Elias Turcatel; Paula Pierozan; Leticia F Pettenuzzo; Mateus Grings; Giselli Scaini; Mariana M Parisi; Guilhian Leipnitz; Emilio L Streck; Florencia M Barbé-Tuana; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2017-01-13       Impact factor: 5.590

2.  Identification of novel γ-secretase-associated proteins in detergent-resistant membranes from brain.

Authors:  Ji-Yeun Hur; Yasuhiro Teranishi; Takahiro Kihara; Natsuko Goto Yamamoto; Mitsuhiro Inoue; Waltteri Hosia; Masakazu Hashimoto; Bengt Winblad; Susanne Frykman; Lars O Tjernberg
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 3.  Nutritional strategies to optimise cognitive function in the aging brain.

Authors:  Devin Wahl; Victoria C Cogger; Samantha M Solon-Biet; Rosilene V R Waern; Rahul Gokarn; Tamara Pulpitel; Rafael de Cabo; Mark P Mattson; David Raubenheimer; Stephen J Simpson; David G Le Couteur
Journal:  Ageing Res Rev       Date:  2016-06-26       Impact factor: 10.895

4.  Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease.

Authors:  Noemí Fabelo; Virginia Martín; Gabriel Santpere; Raquel Marín; Laia Torrent; Isidre Ferrer; Mario Díaz
Journal:  Mol Med       Date:  2011-06-22       Impact factor: 6.354

5.  Identifying Aβ-specific pathogenic mechanisms using a nematode model of Alzheimer's disease.

Authors:  Wail M Hassan; Vishantie Dostal; Brady N Huemann; John E Yerg; Christopher D Link
Journal:  Neurobiol Aging       Date:  2014-10-16       Impact factor: 4.673

Review 6.  The Role of Nutrients in Protecting Mitochondrial Function and Neurotransmitter Signaling: Implications for the Treatment of Depression, PTSD, and Suicidal Behaviors.

Authors:  Jing Du; Ming Zhu; Hongkun Bao; Bai Li; Yilong Dong; Chunjie Xiao; Grace Y Zhang; Ioline Henter; Matthew Rudorfer; Benedetto Vitiello
Journal:  Crit Rev Food Sci Nutr       Date:  2016-11-17       Impact factor: 11.176

7.  Mitochondrial matters of the brain: amyloid formation and Alzheimer's disease introduction.

Authors:  Peter L Pedersen
Journal:  J Bioenerg Biomembr       Date:  2009-10       Impact factor: 2.945

Review 8.  Mitochondria-associated ER membranes and Alzheimer disease.

Authors:  Estela Area-Gomez; Eric A Schon
Journal:  Curr Opin Genet Dev       Date:  2016-05-25       Impact factor: 5.578

9.  The regulation of apoptosis by the downstream regulatory element antagonist modulator/potassium channel interacting protein 3 (DREAM/KChIP3) through interactions with hexokinase I.

Authors:  Theodore A Craig; Pradeep L Ramachandran; H Robert Bergen; Jewel L Podratz; Anthony J Windebank; Rajiv Kumar
Journal:  Biochem Biophys Res Commun       Date:  2013-03-21       Impact factor: 3.575

10.  Translocation of PKC by yessotoxin in an in vitro model of Alzheimer's disease with improvement of tau and β-amyloid pathology.

Authors:  Eva Alonso; Carmen Vale; Mercedes R Vieytes; Luis M Botana
Journal:  ACS Chem Neurosci       Date:  2013-04-08       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.